clinical trial · NCT07400952
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
KeratoconusGLK-221 Ophthalmic SolutionPlacebo Ophthalmic Solution
brief summary
Multi-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.
started
Dec 23, 2025
primary completion
Apr 1, 2027
completion
Apr 1, 2027
last updated
Feb 10, 2026
official title
Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol